These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31476712)

  • 21. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for treatment-resistive methamphetamine psychosis.
    Fujii D
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239-40. PubMed ID: 11983802
    [No Abstract]   [Full Text] [Related]  

  • 23. Brain dysfunction of methamphetamine-associated psychosis in resting state: Approaching schizophrenia and critical role of right superior temporal deficit.
    Yang M; Jia X; Zhou H; Ren P; Deng H; Kong Z; Xie C; Hu W; Jiang W; Lai W; Zhang B; Zhao M; Liu T
    Addict Biol; 2021 Nov; 26(6):e13044. PubMed ID: 33957703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct intrinsic functional brain network abnormalities in methamphetamine-dependent patients with and without a history of psychosis.
    Ipser JC; Uhlmann A; Taylor P; Harvey BH; Wilson D; Stein DJ
    Addict Biol; 2018 Jan; 23(1):347-358. PubMed ID: 27917569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis.
    Uhlmann A; Fouche JP; Koen N; Meintjes EM; Wilson D; Stein DJ
    Psychiatry Res Neuroimaging; 2016 Feb; 248():30-8. PubMed ID: 26792587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine dependence with and without psychotic symptoms: A multi-modal brain imaging study.
    Vuletic D; Dupont P; Robertson F; Warwick J; Zeevaart JR; Stein DJ
    Neuroimage Clin; 2018; 20():1157-1162. PubMed ID: 30380522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
    Reisner AD; Piel JL
    J Forensic Sci; 2020 Jul; 65(4):1382-1383. PubMed ID: 32396213
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.
    Iyo M; Sekine Y; Mori N
    Ann N Y Acad Sci; 2004 Oct; 1025():288-95. PubMed ID: 15542729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower Fractional Anisotropy in the Gray Matter of Amygdala-Hippocampus-Nucleus Accumbens Circuit in Methamphetamine Users: an In Vivo Diffusion Tensor Imaging Study.
    Li Y; Zhou W; Dong H; Shen W; Zhang J; Li F; Zhang L
    Neurotox Res; 2018 May; 33(4):801-811. PubMed ID: 29038922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
    Voce A; Calabria B; Burns R; Castle D; McKetin R
    Subst Use Misuse; 2019; 54(4):549-559. PubMed ID: 30693832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: A systematic review and meta-analysis.
    Cohen-Laroque J; Grangier I; Perez N; Kirschner M; Kaiser S; Sabé M
    Schizophr Res; 2024 May; 267():182-190. PubMed ID: 38554698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular mechanism for methamphetamine-induced memory impairment].
    Nagai T; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Apr; 45(2):81-91. PubMed ID: 20486560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
    Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
    Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
    Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.